CliffBio
small molecule

BROVANA

ARFORMOTEROL TARTRATE

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameBROVANA
Active ingredientARFORMOTEROL TARTRATE
StrengthEQ 0.015MG BASE/2ML
Dosage formSOLUTION
RouteINHALATION
ModalitySmall molecule
FDA approvalOctober 2006
Marketing statusDISCN

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.